Announcements Trials
Browse Landscape

Status

Completed 61Unknown 22Recruiting 21Not yet recruiting 7Terminated 6Active not recruiting 5Withdrawn 3Enrolling by invitation 2

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 18Observational 7

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 2Head & Neck 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 119Neoplasms 100Lung Neoplasms 66Colorectal Neoplasms 62Carcinoma, Hepatocellular 56Carcinoma, Non-Small-Cell Lung 53Prostatic Neoplasms 48Uterine Cervical Neoplasms 36Pancreatic Neoplasms 36Stomach Neoplasms 29Ovarian Neoplasms 28Disease 28Rectal Neoplasms 27Multiple Myeloma 25Leukemia, Myeloid, Acute 21Head and Neck Neoplasms 21Esophageal Neoplasms 21Endometrial Neoplasms 21Recurrence 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Colonic Neoplasms 18Neoplasm Metastasis 17Glioma 17Glioblastoma 17Melanoma 15Lymphoma 15Cholangiocarcinoma 14Urinary Bladder Neoplasms 13Neoplasm, Residual 13Liver Neoplasms 12

Interventions

donafenib 1Fatty Acids, Omega-6 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Carcinoma × Clear all
NCT07365124 2026-04-30

MRinRT

Swansea Bay University Health Board

Not yet recruiting
165 enrolled
CNSGastrointestinal

Carcinoma, Esophageal Neoplasms, Glioblastoma, Neoplasms, Neurologic Manifestations, Pancreatic Neoplasms, Stomach Neoplasms

NCT07501780 2026-03-30

RELI

Maastricht University Medical Center

Not yet recruiting
297 enrolled
Dermatologic

Carcinoma, Carcinoma, Basal Cell, Neoplasms, Neoplasms, Basal Cell

NCT06630273 2026-03-27

(CAN-IMPACT-IO

Canadian Cancer Trials Group

Not yet recruiting
120 enrolled
Tumor-Agnostic

Carcinoma

NCT07332611 2026-01-12

PROTEOMASH

University Hospital, Bordeaux

Not yet recruiting
30 enrolled

Carcinoma, Fatty Liver

NCT07265076 2025-12-04

RO6-HCC

Sohag University

Not yet recruiting
100 enrolled
Tumor-Agnostic

Carcinoma

NCT07180459 2025-09-18

The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study

The First Affiliated Hospital of Zhengzhou University

Not yet recruiting
118 enrolled
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular

NCT06618170 2024-10-02

ETCETERA

Dyameo

Not yet recruiting
80 enrolled
Head & Neck

Margins of Excision, Carcinoma, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡